Kiniksa Pharmaceuticals
KNSA
KNSA
175 hedge funds and large institutions have $991M invested in Kiniksa Pharmaceuticals in 2024 Q3 according to their latest regulatory filings, with 59 funds opening new positions, 55 increasing their positions, 43 reducing their positions, and 15 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
23% more call options, than puts
Call options by funds: $3.13M | Put options by funds: $2.53M
9.98% more ownership
Funds ownership: 87.61% → 97.59% (+10%)
0% more funds holding in top 10
Funds holding in top 10: 3 → 3 (0)
Holders
175
Holding in Top 10
3
Calls
$3.13M
Puts
$2.53M
Top Buyers
| 1 | +$82.4M | |
| 2 | +$20.9M | |
| 3 | +$17.4M | |
| 4 |
Goldman Sachs
New York
|
+$12.7M |
| 5 |
Qube Research & Technologies (QRT)
London,
United Kingdom
|
+$9.71M |
Top Sellers
| 1 | -$39M | |
| 2 | -$24M | |
| 3 | -$19.3M | |
| 4 |
State Street
Boston,
Massachusetts
|
-$17.8M |
| 5 |
Geode Capital Management
Boston,
Massachusetts
|
-$9.14M |